AzTrials
AzTrials

DepressionEMDRNCT07822165

A Migration-Focused Adaptation of EMDR for Psychological Distress Among Turkish Migrants

A study testing EMDR in people with Depression and Anxiety, run by Derin Kubilay at 2 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Many people who migrate to new countries experience significant emotional and psychological challenges. These challenges can include depression, anxiety, stress, and difficulty adjusting to a new culture and society. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Depression, Anxiety, Stress
What is being tested?
EMDR
Could I receive a placebo?
No, everyone receives an active treatment
How many people
38 participants
Where
2 sitesin 2 countries
Study dates
23 Oct 2025to 23 Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • First-generation Turkish adults who are currently residing outside Türkiye
  • Currently residing outside Türkiye for a minimum of 6 months
  • Reporting emotional distress or psychological difficulties related to migration and adaptation to a new country
  • Literate and capable of providing informed consent

Who cannot join

  • Current severe psychiatric condition (psychotic disorders, bipolar disorder, severe depression, or clinically significant suicide risk)
  • Intellectual disability or cognitive impairment that would prevent informed consent or participation
  • Concurrent intensive psychotherapy (more than one individual psychotherapy session per week), or active psychiatric treatment involving medication changes
  • History of alcohol or substance dependence

Trial locations and contacts

2 sites in 2 countries.

2 sites in 2 countries

Netherlands1 site
  • Remote (online delivery via Zoom)

    Utrecht

Other trials in Netherlands

Turkey (Türkiye)1 site
  • Remote (online delivery via Zoom)

    Sivas

Other trials in Turkey (Türkiye)

About this study

Official title: A Migration-Focused Adaptation of EMDR for Psychological Distress Among Turkish Migrants: A Pilot Study

Many people who migrate to new countries experience significant emotional and psychological challenges. These challenges can include depression, anxiety, stress, and difficulty adjusting to a new culture and society. This pilot study examined whether a specialized form of psychotherapy called Eye Movement Desensitization and Reprocessing (EMDR), adapted specifically for migration-related experiences, may help reduce these psychological difficulties and support social adaptation.

Participants were first-generation Turkish adults living in five European countries-the Netherlands, the United Kingdom, France, Sweden, and Austria-who reported emotional distress associated with migration and adaptation challenges. They received 12 weekly individual sessions delivered by licensed EMDR therapists, focusing on distressing experiences and difficulties related to adjusting to life in a new country.

Read more

Before and after the therapy, participants completed questionnaires measuring their levels of depression, anxiety, and stress, and their sense of social adaptation in their new communities.

This is a small single-arm pilot study without a control group. It was designed to provide preliminary information that may inform larger controlled trials.

Read the detailed description

Background and Rationale: Migration has become a major global phenomenon. While migration can provide opportunities, it also appears to involve significant psychological challenges. Migrants commonly report elevated levels of depression, anxiety, stress, and difficulties with social adaptation and integration. Turkish migrants represent one of the largest established migrant communities worldwide, particularly in Europe.

Migration-related psychological distress may emerge from complex interactions between pre-migration experiences, ongoing post-migration stressors, and evolving sense of identity and belonging. Rather than representing a single traumatic event, migration-related distress often appears to reflect accumulated challenges across the migration trajectory, including language barriers, social isolation, discrimination, and reduced social support in the host country.

Intervention: This study examined a migration-focused adaptation of Eye Movement Desensitization and Reprocessing (EMDR), a psychotherapy approach with existing evidence in trauma-related conditions. The study employed a migration-focused protocol that maintained the standard EMDR structure while addressing migration-specific clinical concerns. Treatment consisted of 12 individual weekly online sessions delivered by licensed EMDR therapists.

This study is grounded in the Adaptive Information Processing (AIP) model underlying EMDR therapy. The protocol focused on migration-related experiences, including past difficulties, current triggers, and future challenges. It emphasized strengthening coping resources and establishing a safe place in the host country. Between-session activities and future-oriented exercises were used to support adaptation, reinforce positive experiences, and increase confidence in managing migration-related situations.

Design: This is a single-arm, pre-post pilot study. Psychological distress and social adaptation were assessed at baseline and after completion of the 12-session protocol. Given the absence of a control group, randomization, and blinding, the design does not permit causal inference regarding treatment effects.

Being tested
EMDR
Keywords
EMDR, migration, psychological distress, social adaptation
Medical subject headings
Depression, Anxiety Disorders, Social Adjustment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EMDRBehavioural

    Eye Movement Desensitization and Reprocessing (EMDR) based on the Adaptive Information Processing (AIP) model. EMDR employs bilateral stimulation to facilitate processing of distressing memories and maladaptive cognitions. This intervention addresses migration-related psychological distress. Sessions followed standard EMDR phases including history-taking, preparation, assessment, desensitization, installation, body scan, closure, and re-evaluation. No medication or control condition.

Study groups in NCT07822165
Study groupRoleWhat they receive
EMDR therapyExperimental12 individual weekly online psychotherapy sessions delivered by licensed EMDR therapists. Each session is 45 minutes. Clinical focus of the intervention addresses migration-related psychological distress.
Receives: Behavioral: EMDR

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Depression Anxiety Stress Scales-21 (DASS-21)

    Psychological distress was assessed using the DASS-21, the short form of the original 42-item DASS developed by Lovibond and Lovibond (1995). The Turkish adaptation of the DASS-21 was conducted by Yılmaz et al. (2017). The measure comprises three seven-item subscales assessing symptoms of depression, anxiety, and stress during the preceding week. Items are rated on a four-point Likert-type scale ranging from 0 (Did not apply to me at all) to 3 (Applied to me very much). The DASS-21 contains no reverse-scored items. Each subscale yields a score ranging from 0 to 21, and the total DASS-21 score ranges from 0 to 63.

    The Turkish version has demonstrated adequate internal consistency, with Cronbach's alpha coefficients of .82 for depression, .81 for anxiety, and .76 for stress (Yılmaz et al., 2017). In the present study, depression, anxiety, and stress were specified as the primary psychological outcomes.

    Measured: Baseline (Before the first EMDR session) and post-treatment (Week 12, after final EMDR session)

Secondary outcomes (1)
  1. Social Cohesion Scale for Immigrants (SCSI)

    Social adaptation was assessed using the 28-item Social Cohesion Scale for Immigrants (SCSI), developed by Kaya (2022). The scale comprises six dimensions: Exclusion, belonging, psychological and social support, individual factors, hope and past experience. Thirteen items are reverse scored. Total scores range from 28 to 140, with higher scores indicating greater social adaptation.

    The original validation study reported satisfactory internal consistency across the six subscales: Exclusion (α = .83), Belonging (α = .86), Psychological and Social Support (α = .78), Individual Factors (α = .80), Hope (α = .84), and Past Experiences (α = .82). Internal consistency for the total scale was α = .82 (Kaya, 2022). Social adaptation was specified as the secondary outcome of the study.

    Measured: Baseline (Before the first EMDR session) and post-treatment (Week 12, after final EMDR session)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Sep 2026
  2. Study start23 Oct 2025
  3. Primary completion23 Jul 2026
  4. Study completion23 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
Single-arm design; all participants received the same intervention.
Masking
None (open label)
Enrolment
38 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07822165
Sponsor's protocol ID
EMDR-MIGR-001
Other IDs
61351342/020-1678
Acronym
EMDR
Status last verified
Sep 2026
First submitted
3 Sep 2026
Last updated
16 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data are not publicly available. The data were collected within a psychotherapeutic treatment context, and participants were assured that all information provided would remain confidential; consent for sharing data with third parties was not obtained. The small sample size (N = 16) and the distribution of participants across five countries further limit the possibility of meaningful de-identification. Requests for access will be considered on a case-by-case basis by the corresponding author and would require prior approval from the institutional ethics committee.

Publications

  • de Jongh A, de Roos C, El-Leithy S. State of the science: Eye movement desensitization and reprocessing (EMDR) therapy. J Trauma Stress. 2024 Apr;37(2):205-216. doi: 10.1002/jts.23012. Epub 2024 Jan 28.

    PubMed 38282286
  • Korn DL, Leeds AM. Preliminary evidence of efficacy for EMDR resource development and installation in the stabilization phase of treatment of complex posttraumatic stress disorder. J Clin Psychol. 2002 Dec;58(12):1465-87. doi: 10.1002/jclp.10099.

    PubMed 12455016

Questions about this trial

What is this clinical trial studying?

A study testing EMDR in people with Depression and Anxiety, run by Derin Kubilay at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Netherlands, Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Depression Anxiety Stress Scales-21 (DASS-21) (time frame: Baseline (Before the first EMDR session) and post-treatment (Week 12, after final EMDR session)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07822165, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in